COLORECTAL CANCER (CRC)

Clinical trials for COLORECTAL CANCER (CRC) explained in plain language.

Never miss a new study

Get alerted when new COLORECTAL CANCER (CRC) trials appear

Sign up with your email to follow new studies for COLORECTAL CANCER (CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 29 Not yet recruiting 7 Not yet finished but already full! 6 Completed 5 Terminated 1

Experimental KRAS drug trial halted early – what we know

Disease control Terminated

This early-stage trial tested a new drug called AZD0022 in 17 people with advanced solid tumors (like lung, pancreatic, or colorectal cancer) that have a specific KRASG12D mutation. The study was stopped early, but researchers were checking if the drug is safe and shrinks tumors …

Matched conditions: COLORECTAL CANCER (CRC)

Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control

Last updated May 17, 2026 07:06 UTC

COLORECTAL CANCER (CRC)

Get alerted when new COLORECTAL CANCER (CRC) trials appear

Experimental KRAS drug trial halted early – what we know